ArticleResearch square2026

Propensity-Matched Case Control Study of Anti-Interleukin-23 Therapies in Clostridioides difficile Infection.

Gregory R Madden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.